Journal ArticleDOI
Effect of Intraventricular Injection of Dopamine, Norepinephrine, Acetylcholine, and 5-Hydroxytryptamine on Immunoreactive Somatostatin Release into Rat Hypophyseal Portal Blood
Reads0
Chats0
TLDR
The effect of several putative neurotransmitters in the regulation of somatostatin release from the median eminence into hypophyseal portal blood was investigated in male rats under urethane anesthesia.Abstract:
The effect of several putative neurotransmitters in the regulation of somatostatin release from the median eminence into hypophyseal portal blood was investigated in male rats under urethane anesthesia. Using a specially designed microfraction collector, hypophyseal portal blood was collected at 15-min intervals into five separate tubes containing 2 N acetic acid. Immunoreactive somatostatin (IRS) in the acid-blood mixtures was extracted with acetone, washed with organic solvents, and determined by RIA. Dopamine, norepinephrine, 5-hydroxytryptamine, or acetylcholine in a dose of 10-8 mol/5 μl freshly prepared 5% glucose solution or 5 nl glucose solution alone was injected into the third ventricle immediately after collection of the first blood sample. In 10 control animals, the mean (±SE) secretion rate and concentration of IRS were 3.90=0.66 pg/min and 628 ± 126 pg/ml before injection of 5% glucose, 2.12 ± 0.28 pg/min and 286 ± 22 pg/ml 15 min after the injection, 1.93 ± 0.17 pg/min and 261 ± 18 pg/ml at...read more
Citations
More filters
Journal ArticleDOI
Prolactin: Structure, Function, and Regulation of Secretion
TL;DR: The purpose of this review is to provide a comprehensive survey of the current understanding of prolactin's function and its regulation and to expose some of the controversies still existing.
Journal ArticleDOI
Identification of a cyclic-AMP-responsive element within the rat somatostatin gene.
TL;DR: The studies indicate that transcriptional regulation of the somatostatin gene by cAMP requires protein kinase 2 activity and may depend upon a highly conserved promoter element.
Journal ArticleDOI
Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
TL;DR: The pathophysiology of the GHRH somatostatin-GH-IGF-I feedback axis is reviewed and it is proposed that this system is best viewed as a multivalent feedback network that is exquisitely sensitive to an array of neuroregulators and environmental stressors and genetic restraints.
Journal ArticleDOI
Sexual dimorphism in the control of growth hormone secretion.
TL;DR: A feminization of the liver develops after continuous, but not intermittent, administration of GH to hypophysectomized rats, suggesting that high, infrequent GH pulses with low plasma GH levels in between promotes growth more effectively than an intermediate, rather constant level of plasma GH.
Journal ArticleDOI
Neuroendocrine Control of Growth Hormone Secretion
TL;DR: The secretion of growth hormone is regulated through a complex neuroendocrine control system, especially by the functional interplay of two hypothalamic hypophysiotropic hormones, GH-releasing hormone (GHRH) and somatostatin (SS), exerting stimulatory and inhibitory influences, respectively, on the somatotrope.
References
More filters
Journal ArticleDOI
Principles and Procedures of Statistics.
Journal ArticleDOI
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Paul Brazeau,Wylie Vale,Roger Burgus,Nicholas Ling,Madalyn Butcher,Jean Rivier,Roger Guillemin +6 more
TL;DR: A peptide has been isolated from ovine hypothalamus which, at 1 x 10-9M, inhibits secretion in vitro of immunoreactive rat or human growth hormones and is similarly active in vivo in rats.
Journal ArticleDOI
Hypothalamic-pituitary vasculature: evidence for retrograde blood flow in the pituitary stalk.
TL;DR: Retrograde transport ofpituitary hormones in the pituitary stalk vasculature was investigated in anesthetized male rats in which the pituitsary gland was intact and in animals in which it had been removed 30 to 60 min before use.
Journal ArticleDOI
Radioimmunoassay for GH-release inhibiting hormone.
TL;DR: Plasma protein appears to contain substance(s) immunologically indistinguishable from GH-RIH or to interfere, in a nonspecific manner, with the radioimmunoassay system for GH-Rih, suggesting the antigenic determinant involved the amino acid sequence from position 3-14 of GH- RIH or part of it.